Presentation23 Jan 2024 15:59
I've just listened through it all again. With some issues Cheek is specific about having news 'towards the end of this year or beginning of next'.
He mentions finalising contracts with US partners - dotting the i's and crossing t's - for the FDA application and also mentions 'much more cost effective' means of getting this submitted.
So, we've now had silence for a while on FDA and also NICE review for CYP2C19. I am starting to wonder if if GDR's precarious financial position and it being in the grasp of RF is actually holding things back there??
I am also perturbed by the constant downward pressure on the sp whilst RF are involved. James Cheek needs to somehow get rid of them as quickly as he can. Even if it were by means of a traditional placing and we had to endure more dilution it would show GDR in a far better light as opposed to having a death spiral finance deal hanging around its neck.
2024 IS going to be a much better year for GDR but we are still going to have to be patient. Worst luck. It WILL come good, and spectacularly so I believe, but just not yet.